Grupo Farma
↗Caracas, Venezuela
Grupo Farma is one of Venezuela's most prominent and long-standing pharmaceutical companies, founded in 1941. The company specializes in the development, manufacturing, and distribution of high-quality pharmaceutical products across various therapeutic classes, maintaining a significant market share in the Andean region despite local economic challenges.
The company operates a state-of-the-art manufacturing facility in Maracay, Venezuela, which is certified for Good Manufacturing Practices (GMP). Their business model focuses on branded generics and licensing agreements with multinational pharmaceutical firms to provide essential medicines to the Venezuelan population, covering both retail and institutional markets.
CLASSIFICATION
Company Type:Pharma
Therapeutic Areas:
Industry:Pharmaceuticals
Sub-Industry:Branded Generics and Manufacturing
SIZE & FINANCIALS
Employees:501-1000
Revenue:$50M-$100M (estimated)
Founded:1941
Ownership:private
Status:operating
FUNDING
Stage:Late Stage
Investors:Family-owned / Private Investors
PIPELINE
Stage:Commercial
Lead Drug Stage:Commercial
Modalities:Small molecule
Active Trials:0
Trial Phases:-
FDA Approvals:0
EMA Approvals:0
CORPORATE STRUCTURE
Parent Company:Grupo Farma (Regional)
Subsidiaries:Farma de Colombia, Farma de Ecuador
Key Partnerships:Various multinational pharmaceutical companies for local distribution and representation in Venezuela.
COMPETITION
Position:Leader
Competitors:Laboratorios Leti, Empresas Meyer, Calox International, Genven
LEADERSHIP
Key Executives:
Zurima Parra - Marketing Director
LINKS
Website:farma.com.ve
LinkedIn:LinkedIn Profile
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with Grupo Farma. The information on this page was collected and compiled using AI agents from publicly available sources. While we strive for accuracy, this data may be incomplete, outdated, or contain errors. For official information, please visit the company's website directly. If you notice any inaccurate information, please contact us.